Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Fumihiro Suematsu"'
Autor:
Yuto, Ogasa, Tsuneo, Kuwamura, Takao, Akiyoshi, Soichiro, Murakami, Haruo, Tanaka, Shuyo, Umeda, Fumihiro, Suematsu
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(6)
There are many reports that describe the effectiveness of aromatase inhibitors as endocrine therapy after breast cancer surgery. However, there are few detailed evaluations of patient adherence to anastrozole(ANA)therapy. Here, we evaluated the adher
Autor:
Hirohito Ikeda, Masao Mimemoto, Eiji Yukawa, Hatsumi Aki, Fumihiro Suematsu, Takako Takiguchi, Miho Yukawa
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 36:704-710
Summary What is known and objective: Optimal use of phenobarbital in the neonatal population requires information regarding the drug’s pharmacokinetics and the influence of various factors, such as different routes of administration, on the drug’
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 30:159-163
The population pharmacokinetics of phenobarbital was evaluated using 69 serum concentration measurements obtained from the routine phenobarbital monitoring of 35 neonates and infants. The data were analysed using the nonlinear mixed effects model. A
Autor:
Eiji Yukawa, Hiroshi Imoto, Masao Minemoto, Kunitaka Joo, Kazuyuki Ikeda, Masayo Maeda, Fumihiro Suematsu
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 30:78-82
Autor:
Shigehiro Ohdo, Shun Higuchi, Masao Minemoto, Fumihiro Suematsu, Miho Yukawa, Eiji Yukawa, Yoshinobu Goto
Publikováno v:
Biopharmaceutics & Drug Disposition. 23:173-181
Nonlinear mixed effects modeling was used to estimate the effects of digoxin-calcium channel blockers (verapamil, diltiazem, nifedipine) in 336 serum levels gathered from 172 patients (104 male and 68 female) receiving oral digoxin as hospital in-pat
Autor:
Shun Higuchi, Shigehiro Ohdo, Fumihiro Suematsu, Eiji Yukawa, Miho Yukawa, Yoshinobu Goto, Masao Minemoto
Publikováno v:
European Journal of Clinical Pharmacology. 57:19-24
Objective: The steady-state concentrations of digoxin at trough levels were studied to establish the role of patient characteristics in estimating doses for digoxin using routine therapeutic drug monitoring data. Method: The data (n=448) showing stea
Autor:
Yoshinobu Goto, Shigehiro Ohdo, Shun Higuchi, Miho Yukawa, Fumihiro Suematsu, Masao Minemoto, Eiji Yukawa
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 27:426-431
The steady-state concentrations of digoxin at trough levels were studied to establish the role of infant characteristics in estimating the doses for digoxin based on routine therapeutic drug monitoring data. The data (n = 340) which showed a steady-s
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 24:203-208
SUMMARY concentration for digoxin is difficult because of the lack of a good relationship between the dose and the Background and objectives: Information about the desired effect, the narrow therapeutic range (0·5‐2 ng/ pharmacokinetics of digoxin
Autor:
Hirohito Ikeda, Fumihiro Suematsu, Hatsumi Aki, Takako Takiguchi, Miho Yukawa, Eiji Yukawa, Masao Mimemoto
Publikováno v:
Drugsaging. 28(10)
Background: Optimal use of digoxin in the elderly population requires information about the drug’s pharmacokinetics and the influence of various factors on the drug’s disposition. However, because of sampling restrictions, it is often difficult t
Publikováno v:
Journal of clinical pharmacy and therapeutics. 32(4)
Summary Objective: To establish the role of patient characteristics in estimating doses of digoxin for neonates using routine therapeutic drug monitoring data. Method: The steady-state blood level data (n = 129) after repetitive oral administration i